All News

Catch up on important immunization news from the month of July.

The investigational oral, selective NaV1.8 pain signal inhibitor from Vertex Pharmaceuticals demonstrated a favorable benefit/risk profile in 3 phase 3 trials.

Researchers aimed to address the change in trust individuals exhibited regarding US physicians and hospitals during the COVID-19 pandemic.

Catch up on important diabetes news from the month of July.

Catch up on important pain management news from the month of July.

Recent studies on dry eye disease examined the efficacy of Vitamin D, platelet-rich plasma as a treatment option, and associations with certain systemic medications.

CVS Caremark and the State of Illinois settled a lawsuit due to the company’s failure to pay contracted rebates.

The new FDA-approved presentation will be the company’s third 505(b)(2) injectable added in 2024, expected to launch in the third quarter.

Catch up on important dermatology news from the month of July.

Researchers analyzed the prominence of opioid and methadone prescriptions for hospitalized newborns with substantial morbidities.

Check out this list of our top 10 most read stories from July 2024.

Emily Endres, BSPS, vice president of pharmacy at Innovaccer discuss the evolution of healthcare and provides insights into the industry’s next phase.

Erin Albert, Vice President of Pharmacy Relations and Chief Privacy Officer at Mark Cuban Cost Plus Drug Company, PBC, discussed the changing landscape regarding prescription drug pricing.

A roundtable session discussed the real-world implications of applying Direct and Indirect Remuneration (DIR) fees at the point of sale rather than through retroactive clawback.

Lauren Adair, PharmD, director of network enablement at Outcomes, discussed developments in the expanding role of pharmacists amidst rising health care costs.

Jon Minkin, Enterprise Account Executive at NimbleRx and pharmacy technology expert, discussed how his company can help independent pharmacies unlock revenue opportunities.

In case you missed it, this week we had news about drug expenditures, managing the peak asthma season, successes in HIV drugs, and more.

Check out this recap of articles published on our sister sites during the past week.

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

Check out these important FDA updates from the month of July 2024.

Researchers aimed to address the associations between prenatal cannabis use and maternal health outcomes over a 9-year period.

The American College of Allergy, Asthma, and Immunology (ACAAI) recently released its 5 tips to help children and their parents stay educated on asthma peak month.

Galderma said the FDA has accepted the company’s Biologics License Application for the therapy based on data from the trials.

In the final part of his conversation on Over the Counter, Mayank Amin, PharmD, RPh, MBA, reflects on 5-years worth of learnings at Skippack Pharmacy and offers candid perspectives on the future of community pharmacy.

In part 3 of his conversation with Drug Topics on Over the Counter, Mayank Amin, PharmD, RPh, MBA, continues his inspiring story of reopening Skippack Pharmacy and details the beginnings of The Superman Pharmacist.

Check out these featured Drug Topics interviews from July 2024.

Full efficacy and safety results for the phase 3 PURPOSE 1 trial were announced by Gilead at AIDS 2024.

In a House Committee on Oversight and Accountability hearing, Democrats and Republicans took a bipartisan stance to question the role major PBMs play regarding rising drug costs in the US.